A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart
Status:
Completed
Trial end date:
2020-08-21
Target enrollment:
Participant gender:
Summary
This study will be conducted to investigate the safety of verinurad in healthy volunteers in
combination with allopurinol 300 mg, compared with placebo in particular its effect on
electrocardiogram (ECG), with focus on the QT/QTc interval